A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis

Author:

Adam Kévin12,Cartel Maëlle23,Lambert Mireille12,David Laure23,Yuan Lingli4ORCID,Besson Arnaud3,Mayeux Patrick12,Manenti Stéphane23,Didier Christine23ORCID

Affiliation:

1. Institut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Descartes, Paris, France

2. Ligue Nationale Contre le Cancer, équipe labellisée, Université de Toulouse, Toulouse, France

3. Cancer Research Center of Toulouse, INSERM U1037, CNRS ERL 5294, Université de Toulouse, Toulouse, France

4. Department of Hematology, The Second Xiangya Hospital, Central South University, No.139 Renmin Middle Road, Furong, Changsha. Hunan 410011, China

Abstract

Although the kinase CHK1 is a key player in the DNA damage response (DDR), several studies have recently provided evidence of DDR-independent roles of CHK1, in particular following phosphorylation of its S280 residue. Here, we demonstrate that CHK1 S280 phosphorylation is cell cycle-dependent and peaks during mitosis. We found that this phosphorylation was catalyzed by the kinase PIM2, whose protein expression was also increased during mitosis. Importantly, we identified Polo-Like Kinase 1 (PLK1) as a direct target of CHK1 during mitosis. Genetic or pharmacological inhibition of CHK1 reduced the activating phosphorylation of PLK1 on T210 residue, and recombinant CHK1 was able to phosphorylate T210 of PLK1 in vitro. Accordingly, phospho-S280 CHK1 and PLK1 exhibited similar specific mitotic localizations, and PLK1 was co-immunoprecipitated with phospho-S280 CHK1 from mitotic cell extracts. Moreover, CHK1-mediated phosphorylation of PLK1 was dependent on S280 phosphorylation by PIM2. PIM inhibition reduced cell proliferation and mitotic entry, which was rescued by expressing a T210D phosphomimetic mutant of PLK1. Altogether these data identify a new PIM2/CHK1/PLK1 phosphorylation cascade that regulates different mitotic steps independently of the CHK1 DDR function.

Funder

Ligue Contre le Cancer

Publisher

The Company of Biologists

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3